NKGen Biotech, Inc. Quarterly Deferred Income Tax Assets, Net in USD for Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
NKGen Biotech, Inc. quarterly Deferred Income Tax Assets, Net history and growth rate for Q2 2022.
  • NKGen Biotech, Inc. Deferred Income Tax Assets, Net for the quarter ending June 30, 2022 was $15.4K.
Deferred Income Tax Assets, Net, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $15.4K Jun 30, 2022 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.